Anupriya Singhal, MD, PhD
Gastrointestinal Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Pancreatic cancer and conditions
- Bile duct cancer (cholangiocarcinoma)
- Gastrointestinal cancers and conditions
About Me
- Instructor
I am a medical oncologist who specializes in treating people with pancreatic cancer and bile duct cancers. I also care for people with other gastrointestinal cancers such as colon cancer, rectal cancer, and liver cancer. I see patients at the Rockefeller Outpatient Pavilion.
I work closely with a multidisciplinary team of experts at Memorial Sloan Kettering Cancer Center, which includes surgeons, medical oncologists, pathologists, and radiation oncologists. Together, we work to deliver the best possible care for our patients and their families.
Read more
My clinical and laboratory research at Memorial Sloan Kettering focuses on understanding genetic drivers of pancreatic cancers and developing new therapeutic approaches based on this understanding. Specifically, my work focuses on understanding the biology of tumors with mutations in the KRAS gene, which is a common driver of pancreatic cancers.
Besides treating patients, I also perform laboratory research aimed at understanding how new treatments targeted at the KRAS gene mutations can help patients with gastrointestinal cancers. My goal is to use insights from cancer biology in the lab to suggest new treatment strategies that can make targeted therapies more effective. I am also involved in our clinical trial program for pancreatic and gastrointestinal tumors.
A gastrointestinal (GAS-troh-in-TES-tih-nul) medical oncologist is a cancer doctor who specializes in gastrointestinal (GI) cancers. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.
Conditions I Treat
- Pancreatic cancer and conditions
- Bile duct cancer (cholangiocarcinoma)
- Gastrointestinal cancers and conditions
- Colon cancer
- Rectal cancer
- Liver cancer and conditions
Education
- BA, Harvard College
- MD, Weill Cornell Medical College
- PhD, The Rockefeller University
Residencies
- Internal Medicine, New York Presbyterian Hospital/Weill Cornell Medical Center
Awards and Honors
- The Conquer Cancer Young Investigator Award, American Society for Clinical Oncology (ASCO) (2023)
- Paul Calabresi Career Development Award for Clinical Oncology K12, National Cancer Institute (2023)
- Pancreas Cancer SPORE Career Enhancement Program Award, Memorial Sloan Kettering (2023)
- Break Through Cancer, Conquering KRAS in Pancreatic Cancer Team Lab (2022)
Fellowships
- Medical Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Singhal sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Singhal, A., Styers, H. C., Rub, J., Li, Z., Torborg, S. R., Kim, J. Y., Grbovic-Huezo, O., Feng, H., Tarcan, Z. C., Sahin Ozkan, H., Hallin, J., Basturk, O., Yaeger, R., Christensen, J. G., Betel, D., Yan, Y., Chio, I. I. C., de Stanchina, E., & Tammela, T. (2024). A classical epithelial state drives acute resistance to KRAS inhibition in pancreas cancer. Cancer discovery, 10.1158/2159-8290.CD-24-0740. Advance online publication. https://doi.org/10.1158/2159-8290.CD-24-0740
Singhal, A., Li, B. T., & O’Reilly, E. M. (2024). Targeting KRAS in cancer. Nature medicine, 30(4), 969–983. https://doi.org/10.1038/s41591-024-02903-0
Pitter, K. L., Grbovic-Huezo, O., Joost, S., Singhal, A., Blum, M., Wu, K., Holm, M., Ferrena, A., Bhutkar, A., Hudson, A., Lecomte, N., de Stanchina, E., Chaligne, R., Iacobuzio-Donahue, C. A., Pe’er, D., & Tammela, T. (2022). Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. Cancer research, 82(19), 3549–3560. https://doi.org/10.1158/0008-5472.CAN-22-1742
Visit PubMed for a full listing of Dr. Singhal’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.